SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is a major topic of discussion following its announcement of a strategic manufacturing partnership, expected to significantly enhance production and gross margins for its fingerprint drug screening technology. This news, combined with an extremely low public float, has ignited strong, polarized opinions within the trading community, with many anticipating a substantial short squeeze. Conversely, some warn of a potential "pump and dump" given the company's prior financial hurdles, fueling the stock's high volume and extreme volatility.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp ($ESHA) is trending with intense speculative interest, driven by comparisons to other rapidly surging low-float SPACs and shell companies. The community is buzzing about its extremely tight share structure and high insider ownership, which are seen as catalysts for significant upside potential. High volatility and frequent trading halts are characteristic of the active trading, reflecting strong belief in its capacity for substantial gains.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending strongly after securing FDA approval for NEREUS, its motion-sickness treatment, which is seen as the first new pharmacologic option in decades. The community is actively discussing the drug's significant potential in addressing GLP-1 induced nausea, fueling speculation of a major pharmaceutical buyout and leading many to view the stock as currently undervalued. With additional pipeline approvals anticipated, traders are closely watching for sustained momentum as the market fully integrates this landmark development.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens (XLM) is trending amid a significant price drop, sparking a highly polarized community debate. While many express extreme bearishness, labeling it a "scam" and predicting further declines, a resilient group views current lows as a buying opportunity, citing its ISO compliance, recent network upgrades, and potential for institutional adoption. The broader crypto market sentiment continues to heavily influence discussions around XLM's future trajectory.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending following the FDA's decline to approve a competitor's Cushing's syndrome treatment, which gives Recorlev a clearer path to capture significant market share. The community is buzzing with bullish sentiment, anticipating robust growth and discussing how this immediate catalyst, alongside the company's improving profitability, should drive a substantial re-rating of the stock.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is experiencing polarized sentiment as the year concludes, with many users highlighting significant declines and predicting further downside, potentially influenced by year-end tax-loss selling. Conversely, a vocal part of the community views these suppressed prices as a major accumulation opportunity, anticipating a substantial rally and long-term payoff in the coming years.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending due to a significant price drop following an FDA Complete Response Letter for its relacorilant drug for Cushing syndrome, with the agency requesting additional efficacy evidence. Community discussion is polarized, with some investors calling the sell-off an overreaction given the company's existing profitable drug Korlym and other pipeline assets. The immediate focus is on whether the company can quickly find a path forward with the FDA and if current levels present a "bargain biobuy" or a "falling knife."

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull (BULL) is experiencing intense community discussion as its stock continues a significant downtrend, attributed by many to ongoing post-SPAC dilution and end-of-year tax-loss selling. While some investors are accumulating shares, drawing parallels to early Robinhood, a strong bearish sentiment prevails, highlighting its SPAC origins and concerns about its Chinese affiliation.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is currently a battleground stock, facing intense selling pressure from year-end tax loss harvesting and a recent reiterated 'Sell' rating from a major bank. While bears point to perceived overvaluation and fading hype, bulls are actively accumulating shares, emphasizing strong subscriber growth, new service expansion, and the long-term potential for a significant rebound amid evolving telehealth and GLP-1 market dynamics.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies (BMNR) is trending amidst intense debate surrounding an upcoming shareholder vote on a significant share authorization increase and executive compensation, despite recent updates on its substantial Ethereum holdings and staking. The community is sharply divided, with many expressing frustration over perceived share dilution and the stock's underperformance relative to Ethereum, leading to widespread calls to vote against current management proposals. This contentious backdrop, exacerbated by year-end tax loss selling, fuels speculation on the company's future strategy and shareholder value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Faraday Future Intelligent Electric Sees Unusually High Options Volume (NASDAQ:FFAI)

Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI - Get Free Report) saw some unusual options trading activity on Monday. Traders purchased 30,094 call options on the company. This represents an...

Faraday Future and Faraday X Announce That the First FX Super One Pre-Production Vehicle Has Successfully Rolled Off the Line at its FF AI-Factory in California

Faraday Future and Faraday X Announce That the First FX Super One Pre-Production Vehicle Has Successfully Rolled Off the Line at its FF AI-Factory in California Faraday Future and Faraday X Announce...

AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company's Legal, Compliance, and Governance Strategy

AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company's Legal, Compliance, and Governance Strategy AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the...

YT Jia, Chief Advisor to AIxC Shares Weekly AIxC Investor Update: AIxC Appointed Andrew Grossman as Head of Legal Where he will Take Full Responsibility for the Company's Legal, Compliance, and Governance Framework

YT Jia, Chief Advisor to AIxC Shares Weekly AIxC Investor Update: AIxC Appointed Andrew Grossman as Head of Legal Where he will Take Full Responsibility for the Company's Legal, Compliance, and...

Faraday Future Intelligent Electric (NASDAQ:FFAI) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Faraday Future Intelligent Electric from a "sell" rating to a "hold" rating in a report on Monday...

<ul class="summary-bullets"><li>YT Jia said Faraday Future is ready to integrate fully with Tesla’s Supercharger network and adopt FSD across its vehicles.</li><li>New data showing rapid FSD mileage growth intensified debate over Tesla’s widening autonomy lead and legacy automakers’ slow adoption.</li><li>Analysts said Tesla must prove safety-driver-free robotaxi performance and real-world utility for its Optimus robot.</li></ul><p>Faraday Future Intelligent Electric Inc. (FF) founder and CEO YT Jia opened a new front in the autonomy debate on Wednesday, publicly urging Tesla to collaborate on Full Self-Driving (FSD) technology and positioning his company as fully committed, even as traditional automakers drag their feet.</p><h2 class="st-heading-2"><strong>Faraday Future Makes ‘Clear Position’ On Tesla FSD</strong></h2><p><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/YTJiaFF/status/1993931946406109466">In a post on X</a>, Jia said Faraday Future has already confirmed Supercharger compatibility and that its FF and FX models will be fully integrated into Tesla’s charging network.&nbsp;</p><p>“While traditional automakers hesitate over whether they should “open up,” our position is clear. FF and Tesla operate on the same beliefs and principles, technology-driven thinking, and long-termism. FSD’s industry-leading position deserves respect — it should become a universal language that pushes the entire mobility sector forward,” Jia said.</p><p>He described autonomous driving as a matter of “technological inclusion,” not “simple commercial competition,” and said the future of the technology belongs to all of humanity. He ended his post by tagging Tesla CEO Elon Musk directly: “Let’s talk.”</p><h2 class="st-heading-2"><strong>Musk’s Frustration With Legacy Automakers</strong></h2><p>Jia’s comments arrived as new data highlighted the widening gap between Tesla and traditional carmakers.&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-stock-soars-analyst-warns-fsd-could-make-legacy-carmakers-obsolete-musk-finds-it-crazy-they-don-t-want-it/cL5czupREQy">Melius Research said</a> Tesla’s latest Full Self-Driving software has logged more than 6.5 million miles, putting “unprecedented pressure” on legacy automakers. Analyst Rob Wertheimer said the new FSD version is the “spark” behind a world “about to change, dramatically,” adding that “hundreds of billions in value” could shift toward Tesla over the next five years.&nbsp;</p><p>He said Tesla’s real-world driving data gives it a meaningful lead and warned that many traditional manufacturers risk becoming “obsolete.” Wertheimer also pointed to Tesla’s plans to remove safety monitors from robotaxis in Austin by year-end, expand to seven cities by December, and begin producing the Cybercab robotaxi in April, supported by Tesla’s rapid chip roadmap toward AI5 and AI6.</p><p>In response to the research note, Musk said in a post on X that he has offered to license Tesla’s system but “they don’t want it,” adding that occasional outreach results in talks about “tiny programs in 5 years” with “unworkable requirements.”</p><h2 class="st-heading-2"><strong>Gary Black Says Legacy Auto Won’t Hand Tesla the Wheel</strong></h2><p>On Tuesday, Future Fund Managing Partner&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/gary-black-legacy-automakers-tesla-fsd-elon-musk-crazy/cL521D0REXz">Gary Black said legacy automakers “would never allow Tesla</a> to be in charge of their Full Self-Driving capabilities while still allowing their electric vehicles to be charged at Tesla’s superchargers.”</p><p>Black said “EVs and unsupervised autonomy are table stakes for remaining in the automotive business,” a remark that underscored Jia’s argument that hesitation from older automakers is slowing industry progress.</p><p>In a separate post, Black said Tesla must demonstrate that its robotaxis can operate without safety drivers to show the company has solved unsupervised autonomy at what he described as “99.999% efficacy,” defined as one critical disengagement every 10,000 miles.</p><p>He also said Tesla needs to show how its Optimus humanoid robot can be useful in ways that save time, reduce costs, or improve quality, and that it can be produced at scale.</p><h2 class="st-heading-2"><strong>Stocktwits Draws Bullish Mood For FF And Tesla</strong></h2><p>On Stocktwits, retail sentiment for both Faraday Future and Tesla was ‘bullish,’ with Faraday Future seeing ‘normal’ message volume and Tesla seeing ‘low’ message volume.</p><p>While&nbsp;<a href="https://stocktwits.com/symbol/TSLA">Tesla’s stock</a> has risen 6% so far in 2025,&nbsp;<a href="https://stocktwits.com/symbol/FFAI">Faraday Future’s stock</a> has declined 51% over the same period.&nbsp;</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

LeEco Founder and CEO YT Jia unveils Faraday Future's FF 91 prototype electric crossover vehicle during a press event for CES 2017 on January 3, 2017. (Photo by Ethan Miller/Getty Images)

‘Let’s Talk, Elon’: Faraday Future CEO Makes A Public Push For Tesla FSD Alliance While Legacy Carmakers 'Hesitate'

YT Jia said Faraday Future is ready to integrate fully with Tesla’s Supercharger network and adopt FSD across its vehicles.

Equity

Litchfield Hills Research Estimates FFAI FY2025 Earnings

Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI - Free Report) - Investment analysts at Litchfield Hills Research issued their FY2025 earnings per share (EPS) estimates for Faraday Future...

What is Sidoti Csr's Estimate for FFAI FY2025 Earnings?

Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI - Free Report) - Analysts at Sidoti Csr dropped their FY2025 earnings estimates for Faraday Future Intelligent Electric in a report released on...

Faraday Future Intelligent Electric (NASDAQ:FFIE) Trading Down 0.9% - What's Next?

Faraday Future Intelligent Electric (NASDAQ:FFIE) Trading Down 0.9% - Should You Sell...

Faraday Future Loss Widens In Q3

(RTTNews) - Faraday Future Intelligent Electric Inc. (FFAI, FFAIW), on Friday, reported its net loss widened in the third quarter compared with the previous year...

This account has been verified as an official FFAI representative.

Verified Account

Faraday Future

Faraday Future Intelligent Electric, Inc. is an emerging growth company, which manufactures electric vehicles. The company was founded by Jia Yueting in May 2014 and is headquartered in Gardena, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.36	--	--	N/A
Q3 '25	-$0.36	-$1.55	-330.56%	MISSED
Q2 '25	--	-$1.20	--	N/A
Q2 '24	--	-$12.40	--	N/A
Q4 '23	-$140.40	--	--	N/A

FFAI
Faraday Future Intelligent Electric Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest FFAI News

FFAIFaraday Future Intelligent Electric Inc